Etonogestrel sustained release (Orbis Biosciences)

N/A

Report date: 2024/09/12 09:59:00

Base Information

Drug NameEtonogestrel sustained release (Orbis Biosciences)
Drug Alias NameDARE-204/214DARE 204/214DARE-204DARE-214ORB-204 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsProgesterone receptorEstrogen receptors
Therapy Area/IndicationsContraception
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaré Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesDaré Bioscience Inc
Inactive CompaniesN/A
Active IndicationsContraception
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A